Welcome to our dedicated page for DANAHER /DE/ SEC filings (Ticker: DHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on DANAHER /DE/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into DANAHER /DE/'s regulatory disclosures and financial reporting.
Danaher (DHR) — Form 144 notice of proposed sale. A company affiliate filed to sell 5,174 shares of Danaher common stock on or after 11/10/2025 on the NYSE through Fidelity Brokerage Services LLC. The filing lists an aggregate market value of $1,088,703.60 for the proposed sale.
The shares derive from multiple acquisitions: 403 shares vested on 02/24/2025, 255 on 03/01/2025, 340 on 05/15/2025 (all as restricted stock vesting/compensation), and 4,176 shares from options granted 02/24/2018 and exercised for cash on 11/10/2025.
Shares outstanding were 706,349,563; this is a baseline figure, not the amount being sold. The signer represents they do not know of undisclosed material adverse information regarding the issuer’s operations.
Danaher (DHR) announced a planned Board change. Director John T. Schwieters will not stand for reelection at the 2026 annual meeting and will retire at that time. The company stated his decision was not due to any disagreement on operations, policies, or practices.
Following his retirement, the Board size will be reduced from thirteen to twelve members. This is a governance update with no operational or financial changes disclosed.
Danaher (DHR) insider Mitchell P. Rales reported stock sales on a Form 4. On 10/31/2025, he sold a total of 600,000 shares of common stock in three transactions at weighted average prices of $215.67, $216.26, and $217.17. He is listed as a Director and Officer (Chairman of Exec. Committee).
Following these sales, Rales directly owned 990,228 shares. Indirect holdings listed include 912,654 shares through the Mitchell P. Rales Family Trust, 25,671,000 shares through single-member LLCs, and 667 shares via a 401(k) plan. The filing also lists 3,256 shares held by a trust for his daughter, with Rales disclaiming beneficial ownership of those shares. Price ranges for the sales were disclosed as $215.00–$215.99, $216.00–$216.99, and $217.00–$217.66.
Danaher (DHR) reported a Form 4 for director Feroz Dewan.
On 10/31/2025, the reporting person acquired 153.431 phantom shares under the Non‑Employee Directors Deferred Compensation Plan at a reference price of $215.38. Following the acquisition, 1,859.516 derivative securities were beneficially owned, held directly. Phantom shares convert into common stock on a one‑for‑one basis upon distribution, and the amounts are fully vested.
Danaher (DHR) director Alan G. Spoon reported a routine equity compensation transaction. On 10/31/2025, he acquired 195.724 phantom shares under the Non‑Employee Directors Deferred Compensation Plan, tied to a reference closing price of $215.38. Following the transaction, he beneficially owned 30,367.495 derivative (phantom) shares, held directly.
Per the plan, phantom shares reflect deferred director fees and convert into Danaher common stock on a one‑for‑one basis upon distribution. The derivative shows a $0 conversion/exercise price, consistent with fee deferrals rather than an option grant.
Danaher Corporation reported a director’s Form 4 showing the acquisition of 160.891 phantom shares on 10/31/2025 under the Non-Employee Directors Deferred Compensation Plan. The plan converts deferred director fees (including dividend accruals) into notional shares using the NYSE closing price on the transaction date, listed as $215.38.
The phantom shares convert into common stock on a one-for-one basis upon distribution, and the reporting person is fully vested in amounts deferred. Following the transaction, 6,888.48 derivative securities were beneficially owned.
Danaher (DHR) director Elias A. Zerhouni reported a routine deferred‑compensation transaction. On 10/31/2025, he acquired 203.472 phantom shares under the Non‑Employee Directors Deferred Compensation Plan, reflecting quarterly fee deferral.
The Plan converts deferred amounts into notional Danaher shares using the NYSE closing price; the filing lists $215.38 as the reference price. Phantom shares convert into common stock on a one‑for‑one basis upon distribution. Following this transaction, he beneficially owns 18,012.058 derivative securities, held directly.
Danaher (DHR): Director A. Shane Sanders reported the acquisition of 186.308 phantom shares on 10/31/2025 on a Form 4. The award was made under the Non-Employee Directors Deferred Compensation Plan, which converts deferred director fees (and dividend accruals) into notional shares based on the NYSE closing price on the quarterly date. The filing notes a reference closing price of $215.38.
Following this transaction, Sanders beneficially owned 2,536.686 derivative securities (phantom shares), held directly. Phantom shares convert into Danaher common stock on a one-for-one basis upon distribution, and the reporting person is fully vested in all amounts deferred under the plan.
Danaher (DHR) reported a routine insider transaction: director Linda Filler acquired 13.208 phantom shares on 10/31/2025 under the company’s Non‑Employee Directors Deferred Compensation Plan. These notional units track Danaher common stock and are valued using the NYSE closing price of $215.38 on the transaction date.
The phantom shares convert into Danaher common stock on a one‑for‑one basis upon distribution, and the reporting person is fully vested under the plan. Following the transaction, Filler beneficially owned 8,903.266 derivative securities, reported as directly owned.
Danaher Corporation (DHR) reported an insider equity compensation update. Director Teri List acquired 11.322 phantom shares on 10/31/2025 under the Non-Employee Directors Deferred Compensation Plan, which converts deferred cash fees into notional Danaher common stock equivalents based on the closing price on the transaction date.
The filing lists a reference price of $215.38 per share, reflecting the NYSE closing price used for the quarter’s deferral calculation. Phantom shares convert into Danaher common stock on a one-for-one basis upon distribution, and the reporting person is fully vested in amounts deferred under the plan. Following this transaction, Ms. List beneficially owned 7,631.994 derivative (phantom) shares, held directly.